• YOU ARE AT |
  • Home
  • News
  • Biosidus at the CphI 2016

New Technologies/ view all

  • Transgenic animals to produce therapeutic proteins

    Biosidus has concluded is working on novel technologies for high-yield and cost-effective production of recombinant proteins for pharmaceutical applications.

  • Gene Therapy

    Angiogenesis and muscle regeneration using the vascular endothelial growth factor.
    Vascular endothelial growth factor (VEGF) is a protein that stimulates the growth of blood vessels.

  • Biodiversity

    White Genome Project
    Yet another groundbreaking initiative for Biosidus is the White Genome Project, which aims to isolate, identify and characterize Antarctic bacterial strains for further sequencing of the complete genome.


Biosidus at the CphI 2016

Biosidus will be present at the CPhI 2016, the leading pharmaceutical networking event worldwide, which will take place in Barcelona, Spain, on October 4-6, 2016.

Please do not miss the chance to visit us at the Biopharmaceuticals Zone, Stand 6J56. If you would like to fix an appointment in advance, please contact our Business Development staff (out-licensing:, in-licensing: